Pegylated graphene oxide for 4′-fluorouridine delivery: An Ab Initio approach to antiviral therapy.
Adekoya, Oluwasegun Chijioke Adekoya, Gbolahan Joseph Liu, Wanjun Sadiku, Emmanuel Rotimi Hamam, Yskandar
Adekoya, Oluwasegun Chijioke
Adekoya, Gbolahan Joseph
Liu, Wanjun
Sadiku, Emmanuel Rotimi
Hamam, Yskandar
Citations
Altmetric:
Abstract
Effective antiviral drug delivery systems, such as for 4′-Fluorouridine (4′-FlU), are crucial for addressing viral infections like COVID-19. This study used ab-initio analysis to examine interactions between 4′-FlU and graphene oxide (GO)-based carriers, with and without polyethylene glycol (PEG) functionalization, across various physiological conditions. Non-PEGylated GO showed strong gas-phase binding (−103.36 kcal mol−1), supporting systemic stability, while PEGylation reduced aqueous-phase binding (−33.72 kcal mol−1), enhancing biocompatibility and circulation. Adsorption energies were significant in acidic and alkaline environments, with PEGylation intensifying alkaline interactions (−118.42 kcal mol−1). Charge transfer dynamics, influenced by pH and PEGylation, revealed enhanced stability under acidic conditions, suitable for tumor microenvironments. Hydrogen bonding stabilized GO-drug complexes, ensuring prolonged release. PEGylated GO excelled in acidic environments, especially for tumor delivery, as confirmed by miscibility studies and controlled release kinetics. Thermodynamic and quantum chemical analyses highlighted environmental factors and PEGylation in optimizing stability and reactivity. GO/PEG-4′-FlU is ideal for localized drug delivery in acidic tumors, while GO/4′-FlU supports systemic delivery requiring broader dispersion. This research lays the groundwork for nanotechnology-based antiviral strategies and the design of adaptable drug delivery systems for both systemic and localized applications.
Description
Date
2024-01-01
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Research Projects
Organizational Units
Journal Issue
Keywords
COVID-19, Graphene Oxide, 4′-Fluorouridine